文献速递血液净化与透析

骨桥蛋白经CD44介导扰动流诱导的内皮间质转化是血液透析通路动静脉内瘘内膜增生的新机制

Osteopontin mediation of disturbed flow-induced endothelial mesenchymal transition through CD44 is a novel mechanism of neointimal hyperplasia in arteriovenous fistulae for hemodialysis access.
PubMed 文献 · Kidney Int · 2023-01-13

研究在大鼠动静脉瘘模型、Cdh5-Cre/ERT2;ROSA26-tdTomato转基因小鼠及体外培养人脐静脉内皮细胞中,探讨扰动流是否通过骨桥蛋白/CD44轴诱导内皮间质转化(EndMT)参与动静脉内瘘内膜增生(NH)。结果显示EndMT见于动静脉交界扰动流区域,内皮来源细胞占新生内膜细胞24%,CD44敲除小鼠NH较野生型减少35%。

要点

  • 动静脉交界扰动流区域可见EndMT及骨桥蛋白、CD44表达。
  • 内皮来源细胞占动静脉瘘新生内膜细胞的24%。
  • CD44敲除小鼠内膜增生较野生型减少35%。

核心结论

  • 骨桥蛋白/CD44轴调控扰动流诱导的EndMT,在动静脉内瘘内膜增生中起重要作用,可能作为预防内瘘功能障碍的潜在治疗靶点。

研究设计与样本

  • 大鼠动静脉腔瘘模型,采用免疫染色、双功超声与电镜检查。
  • Cdh5-Cre/ERT2;ROSA26-tdTomato转基因小鼠进行内皮谱系追踪。
  • 体外培养人脐静脉内皮细胞(HUVECs),采用平行板系统施加低振荡壁剪切应力。
  • CD44敲除小鼠动静脉瘘模型与野生型比较。
  • 尿毒症患者功能不良动静脉瘘标本行免疫染色。

主要发现

  • 大鼠动静脉交界附近可见EndMT及骨桥蛋白与CD44表达,双功超声确认该区域暴露于扰动流。
  • 电镜显示动静脉交界腔面内皮细胞呈内皮与平滑肌细胞混合超微结构表型。
  • 内皮谱系追踪显示EndMT自早期即参与动静脉瘘内膜增生,内皮来源细胞占新生内膜细胞24%。
  • 体外骨桥蛋白处理诱导HUVECs发生EndMT,CD44敲低可抑制该过程。
  • 平行板系统低振荡壁剪切应力诱导HUVECs发生EndMT,骨桥蛋白或CD44敲低均可抑制。

临床怎么用

  • 作者认为骨桥蛋白/CD44轴可能作为预防动静脉内瘘功能障碍的潜在治疗靶点。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

In dysfunctional arteriovenous fistulae (AVF) for hemodialysis access, neointimal hyperplasia (NH) is prone to occur in the region exposed to disturbed flow. We hypothesized that disturbed flow contributes to NH in AVF by inducing endothelial mesenchymal transition (EndMT) through activation of the osteopontin/CD44 axis. In rats with aortocaval fistula, a rodent model of AVF, we demonstrated development of EndMT and expression of osteopontin and CD44 specifically in the vicinity of the arteriovenous junction using immunostaining. Duplex scan confirmed this region was exposed to a disturbed flow. A mixed ultrastructural phenotype of endothelium and smooth muscle cells was found in luminal endothelial cells of the arteriovenous junction by electron microscopy ascertaining the presence of EndMT. Endothelial lineage tracing using Cdh5-Cre/ERT2;ROSA26-tdTomato transgenic mice showed that EndMT was involved in NH of AVF since the early stage and that the endothelial-derived cells contributed to 24% of neointimal cells. In human umbilical vein endothelial cells (HUVECs) in culture, osteopontin treatment induced EndMT, which was suppressed by CD44 knockdown. Exposure to low oscillatory wall shear stress using a parallel-plate system induced EndMT in HUVECs, also suppressed by osteopontin or CD44 knockdown. In AVF of CD44 knockout mice, EndMT was mitigated and NH decreased by 35% compared to that in wild-type mice. In dysfunctional AVF of patients with uremia, expressions of osteopontin, CD44, and mesenchymal markers in endothelial cells overlying the neointima was also found by immunostaining. Thus, the osteopontin/CD44 axis regulates disturbed flow-induced EndMT, plays an important role in neointimal hyperplasia of AVF, and may act as a potential therapeutic target to prevent AVF dysfunction.

来源:Kidney Int,查看原文。版权归原作者所有。

引用

  1. Chang CJ, Lai YJ, Tung YC, et al. Osteopontin mediation of disturbed flow-induced endothelial mesenchymal transition through CD44 is a novel mechanism of neointimal hyperplasia in arteriovenous fistulae for hemodialysis access. Kidney Int. 2023. PMID: 36646166. doi:10.1016/j.kint.2022.12.022

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。